Identification of a NUAK1/2 Inhibitor as a Macrophage-Polarizing Compound by a Machine Learning-Based Phenotypic Cell

Johanna B Brüggenthies-Brunner1, Jakob Dittmer2, Julia Sauer3

  • 1Eye Health & Research Beyond Borders, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach a.d. Riss, Germany.

Related Concept Videos